Skip to main content
Erschienen in: Annals of Surgical Oncology 13/2016

05.07.2016 | Gynecologic Oncology

Impact of Radical Hysterectomy on Survival in Patients with Stage 2 Type1 Endometrial Carcinoma: A Matched Cohort Study

verfasst von: Juliette Phelippeau, MD, Martin Koskas, MD, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 13/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

In cases of stage 2 endometrial cancers (ECs), a radical hysterectomy is recommended; however, its benefits are poorly documented.

Objective

The aim of this study was to determine whether a primary radical hysterectomy improves specific and overall survival compared with a simple hysterectomy in stage 2 EC.

Methods

Data from all women with type 1 EC and International Federation of Gynecology and Obstetrics (FIGO) 2009 stage 2 who underwent surgical treatment between January 1998 and December 2012 were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. Women treated with radical hysterectomy were matched with women treated with simple hysterectomy according to demographic and tumoral criteria. The primary endpoint was cancer-related survival.

Results

One-to-two matching enabled a comparison of 273 patients who underwent a radical hysterectomy for stage 2 EC (case group) with 546 patients who received a simple hysterectomy (control group). The probability of cancer-related survival was not significantly different in the case group compared with the control group (p = 0.08), and the 3-year cancer-related survivals in the radical and simple hysterectomy groups were 88.7 and 94.1 %, respectively. Following adjustment for radiation, survival analysis indicated there was no survival difference between the two groups with regard to cancer-related survival or overall survival.

Conclusion

The present study indicates that for patients with stromal cervical invasion and type 1 EC, the type of hysterectomy does not impact cancer-related or overall survival, even after adjustment for adjuvant radiation. This finding suggests that additional, randomized clinical studies are required.
Literatur
1.
Zurück zum Zitat Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.CrossRefPubMed Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.CrossRefPubMed
2.
Zurück zum Zitat Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105(2):103–4.CrossRefPubMed Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105(2):103–4.CrossRefPubMed
3.
Zurück zum Zitat Creasman W. Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet. 2009;105(2):109.CrossRefPubMed Creasman W. Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet. 2009;105(2):109.CrossRefPubMed
4.
Zurück zum Zitat Amant F, Mirza MR, Koskas M, Creutzberg CL. Cancer of the corpus uteri. Int J Gynaecol Obstet. 2015;131 Suppl 2:S96–104.CrossRefPubMed Amant F, Mirza MR, Koskas M, Creutzberg CL. Cancer of the corpus uteri. Int J Gynaecol Obstet. 2015;131 Suppl 2:S96–104.CrossRefPubMed
5.
Zurück zum Zitat Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C, et al. Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24 Suppl 6:vi33–8. Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C, et al. Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24 Suppl 6:vi33–8.
6.
Zurück zum Zitat NCCN clinical practice guidelines in oncology (NCCN guidelines): uterine neoplasms. 2014. NCCN clinical practice guidelines in oncology (NCCN guidelines): uterine neoplasms. 2014.
7.
Zurück zum Zitat Boente MP, Yordan EL, McIntosh DG, Grendys EC, Orandi YA, Davies S, et al. Prognostic factors and long-term survival in endometrial adenocarcinoma with cervical involvement. Gynecol Oncol. 1993;51(3):316–22.CrossRefPubMed Boente MP, Yordan EL, McIntosh DG, Grendys EC, Orandi YA, Davies S, et al. Prognostic factors and long-term survival in endometrial adenocarcinoma with cervical involvement. Gynecol Oncol. 1993;51(3):316–22.CrossRefPubMed
8.
Zurück zum Zitat Sartori E, Gadducci A, Landoni F, Lissoni A, Maggino T, Zola P, et al. Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adjuvant radiation therapy. Int J Gynecol Cancer. 2001;11(6):430–7.CrossRefPubMed Sartori E, Gadducci A, Landoni F, Lissoni A, Maggino T, Zola P, et al. Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adjuvant radiation therapy. Int J Gynecol Cancer. 2001;11(6):430–7.CrossRefPubMed
9.
Zurück zum Zitat Lee TS, Kim JW, Kim DY, Kim YT, Lee KH, Kim BG, et al. Necessity of radical hysterectomy for endometrial cancer patients with cervical invasion. J Korean Med Sci. 2010;25(4):552–6.CrossRefPubMedPubMedCentral Lee TS, Kim JW, Kim DY, Kim YT, Lee KH, Kim BG, et al. Necessity of radical hysterectomy for endometrial cancer patients with cervical invasion. J Korean Med Sci. 2010;25(4):552–6.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Cornelison TL, Trimble EL, Kosary CL. SEER data, corpus uteri cancer: treatment trends versus survival for FIGO stage II, 1988–1994. Gynecol Oncol. 1999;74(3):350–5.CrossRefPubMed Cornelison TL, Trimble EL, Kosary CL. SEER data, corpus uteri cancer: treatment trends versus survival for FIGO stage II, 1988–1994. Gynecol Oncol. 1999;74(3):350–5.CrossRefPubMed
11.
Zurück zum Zitat Wright JD, Fiorelli J, Kansler AL, Burke WM, Schiff PB, Cohen CJ, et al. Optimizing the management of stage II endometrial cancer: the role of radical hysterectomy and radiation. Am J Obstet Gynecol. 2009;200(4):419.e1–7. Wright JD, Fiorelli J, Kansler AL, Burke WM, Schiff PB, Cohen CJ, et al. Optimizing the management of stage II endometrial cancer: the role of radical hysterectomy and radiation. Am J Obstet Gynecol. 2009;200(4):419.e1–7.
12.
Zurück zum Zitat Rutledge F. The role of radical hysterectomy in adenocarcinoma of the endometrium. Gynecol Oncol. 1974;2(2–3):331–47.CrossRefPubMed Rutledge F. The role of radical hysterectomy in adenocarcinoma of the endometrium. Gynecol Oncol. 1974;2(2–3):331–47.CrossRefPubMed
13.
Zurück zum Zitat Takano M, Ochi H, Takei Y, Miyamoto M, Hasumi Y, Kaneta Y, et al. Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)? Br J Cancer. 2013;109(7):1760–5.CrossRefPubMedPubMedCentral Takano M, Ochi H, Takei Y, Miyamoto M, Hasumi Y, Kaneta Y, et al. Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)? Br J Cancer. 2013;109(7):1760–5.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Ries LAG, Kosary CL, Hankey BF, Miller BA, Edwards BK (eds). SEER cancer statistics review: 1973–1995. Bethesda, MD, National Cancer Institute; 1998. Ries LAG, Kosary CL, Hankey BF, Miller BA, Edwards BK (eds). SEER cancer statistics review: 1973–1995. Bethesda, MD, National Cancer Institute; 1998.
15.
Zurück zum Zitat FIGO (International Federation of Gynecology and Obstetrics). FIGO stages, 1988 revision. Gynecol Oncol 1989; 35: 125–6. FIGO (International Federation of Gynecology and Obstetrics). FIGO stages, 1988 revision. Gynecol Oncol 1989; 35: 125–6.
16.
Zurück zum Zitat Piver MS, Rutledge F, Smith JP. Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol. 1974;44(2):265–72.PubMed Piver MS, Rutledge F, Smith JP. Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol. 1974;44(2):265–72.PubMed
17.
Zurück zum Zitat Lanciano RM, Curran WJ, Greven KM, Fanning J, Stafford P, Randall ME, et al. Influence of grade, histologic subtype, and timing of radiotherapy on outcome among patients with stage II carcinoma of the endometrium. Gynecol Oncol. 1990;39(3):368–73.CrossRefPubMed Lanciano RM, Curran WJ, Greven KM, Fanning J, Stafford P, Randall ME, et al. Influence of grade, histologic subtype, and timing of radiotherapy on outcome among patients with stage II carcinoma of the endometrium. Gynecol Oncol. 1990;39(3):368–73.CrossRefPubMed
18.
Zurück zum Zitat Boente MP, Orandi YA, Yordan EL, Miller A, Graham JE, Kirshner C, et al. Recurrence patterns and complications in endometrial adenocarcinoma with cervical involvement. Ann Surg Oncol. 1995;2(2):138–44.CrossRefPubMed Boente MP, Orandi YA, Yordan EL, Miller A, Graham JE, Kirshner C, et al. Recurrence patterns and complications in endometrial adenocarcinoma with cervical involvement. Ann Surg Oncol. 1995;2(2):138–44.CrossRefPubMed
19.
Zurück zum Zitat Feltmate CM, Duska LR, Chang Y, Flynn CE, Nikrui N, Kiggundu E, et al. Predictors of recurrence in surgical stage II endometrial adenocarcinoma. Gynecol Oncol. 1999;73(3):407–11.CrossRefPubMed Feltmate CM, Duska LR, Chang Y, Flynn CE, Nikrui N, Kiggundu E, et al. Predictors of recurrence in surgical stage II endometrial adenocarcinoma. Gynecol Oncol. 1999;73(3):407–11.CrossRefPubMed
20.
Zurück zum Zitat Ayhan A, Taskiran C, Celik C, Yuce K. The long-term survival of women with surgical stage II endometrioid type endometrial cancer. Gynecol Oncol. 2004;93(1):9–13.CrossRefPubMed Ayhan A, Taskiran C, Celik C, Yuce K. The long-term survival of women with surgical stage II endometrioid type endometrial cancer. Gynecol Oncol. 2004;93(1):9–13.CrossRefPubMed
21.
Zurück zum Zitat Cohn DE, Woeste EM, Cacchio S, Zanagnolo VL, Havrilesky LJ, Mariani A, et al. Clinical and pathologic correlates in surgical stage II endometrial carcinoma. Obstet Gynecol. 2007;109(5):1062–7.CrossRefPubMed Cohn DE, Woeste EM, Cacchio S, Zanagnolo VL, Havrilesky LJ, Mariani A, et al. Clinical and pathologic correlates in surgical stage II endometrial carcinoma. Obstet Gynecol. 2007;109(5):1062–7.CrossRefPubMed
22.
Zurück zum Zitat Sharma C, Deutsch I, Lewin SN, Burke WM, Qiao Y, Sun X, et al. Lymphadenectomy influences the utilization of adjuvant radiation treatment for endometrial cancer. Am J Obstet Gynecol. 2011;205(6):562.e1–9. Sharma C, Deutsch I, Lewin SN, Burke WM, Qiao Y, Sun X, et al. Lymphadenectomy influences the utilization of adjuvant radiation treatment for endometrial cancer. Am J Obstet Gynecol. 2011;205(6):562.e1–9.
23.
Zurück zum Zitat Parthasarathy A, Kapp DS, Cheung MK, Shin JY, Osann K, Chan JK. Adjuvant radiotherapy in incompletely staged IC and II endometrioid uterine cancer. Obstet Gynecol. 2007;110(6):1237–43.CrossRefPubMed Parthasarathy A, Kapp DS, Cheung MK, Shin JY, Osann K, Chan JK. Adjuvant radiotherapy in incompletely staged IC and II endometrioid uterine cancer. Obstet Gynecol. 2007;110(6):1237–43.CrossRefPubMed
24.
Zurück zum Zitat Mariani A, Webb MJ, Keeney GL, Calori G, Podratz KC. Role of wide/radical hysterectomy and pelvic lymph node dissection in endometrial cancer with cervical involvement. Gynecol Oncol. 2001;83(1):72–80.CrossRefPubMed Mariani A, Webb MJ, Keeney GL, Calori G, Podratz KC. Role of wide/radical hysterectomy and pelvic lymph node dissection in endometrial cancer with cervical involvement. Gynecol Oncol. 2001;83(1):72–80.CrossRefPubMed
Metadaten
Titel
Impact of Radical Hysterectomy on Survival in Patients with Stage 2 Type1 Endometrial Carcinoma: A Matched Cohort Study
verfasst von
Juliette Phelippeau, MD
Martin Koskas, MD, PhD
Publikationsdatum
05.07.2016
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 13/2016
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-016-5372-3

Weitere Artikel der Ausgabe 13/2016

Annals of Surgical Oncology 13/2016 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.